CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Dupilumab Monotherapy in Patients ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03054428
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:13.690476+00:00
Published At: 2019-07-23T00:00:00+00:00
Record Updated At: 2019-07-23
Results Posted At: 2019-07-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Moderate-to-Severe Atopic Dermatitis", "Dermatitis, Dermatitis Atopic", "Eczema, Skin Diseases, Skin", "Diseases Genetic, Genetic", "Diseases Inborn, Skin", "Disease, Eczematous Skin", "Hypersensitivity, Immediate", "Hypersensitivity, Immune System Diseases", "Dermatitis, Atopic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-07-23"
protocolSection.identificationModule.nctId: "NCT03054428"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Dupilumab Monotherapy in Patients \u226512 to \u003c18 Years of Age, With Moderate-to-severe Atopic Dermatitis"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-07-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.